HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Eugenia Abella Selected Research

Lymphoproliferative Disorders (Lymphoproliferative Disorder)

10/2008Prospective study on the practice of central nervous system prophylaxis and treatment in non-Hodgkin's lymphoma in Spain.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Eugenia Abella Research Topics

Disease

5Multiple Myeloma
12/2022 - 05/2019
4Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2019 - 01/2015
4B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
01/2018 - 01/2008
3Neoplasms (Cancer)
12/2022 - 06/2011
3Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
06/2019 - 02/2008
3Philadelphia Chromosome
01/2019 - 10/2012
3Hodgkin Disease (Hodgkin's Disease)
10/2009 - 09/2002
2Plasmacytoma
01/2022 - 05/2019
2Lymphoma (Lymphomas)
03/2011 - 02/2008
2Infections
10/2009 - 10/2008
1Smoldering Multiple Myeloma
12/2022
1COVID-19
12/2022
1Monoclonal Gammopathy of Undetermined Significance
12/2022
1Respiratory Insufficiency (Respiratory Failure)
09/2019
1Cardiotoxicity
06/2019
1Disease Progression
03/2019
1Lymphocytosis
01/2018
1HIV Infections (HIV Infection)
04/2015
1Leukemia
01/2015
1B-Cell Lymphoma (Lymphoma, B Cell)
06/2012
1Non-Hodgkin Lymphoma (Lymphosarcoma)
06/2011
1Lymphoproliferative Disorders (Lymphoproliferative Disorder)
10/2008
1AIDS-Related Lymphoma (Lymphoma, AIDS Related)
02/2008
1Pathologic Complete Response
02/2007
1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL)
01/2006

Drug/Important Bio-Agent (IBA)

5Rituximab (Mabthera)FDA Link
12/2013 - 02/2008
4Cyclophosphamide (Cytoxan)FDA LinkGeneric
12/2013 - 01/2008
4Doxorubicin (Adriamycin)FDA LinkGeneric
03/2011 - 02/2007
3Mitoxantrone (Novantrone)FDA LinkGeneric
12/2013 - 01/2008
3fludarabineIBA
12/2013 - 01/2008
2daratumumabIBA
01/2022 - 01/2020
2Dexamethasone (Maxidex)FDA LinkGeneric
09/2019 - 05/2019
2pro-brain natriuretic peptide (1-76)IBA
06/2019 - 06/2011
2Asparaginase (Elspar)FDA Link
01/2018 - 02/2007
2AntigensIBA
01/2018 - 01/2006
2Bleomycin (Blenoxane)FDA LinkGeneric
10/2009 - 02/2007
2Dacarbazine (DIC)FDA LinkGeneric
10/2009 - 02/2007
2Vinblastine (Vinblastine Sulfate)FDA Link
10/2009 - 02/2007
2Prednisone (Sone)FDA LinkGeneric
02/2008 - 02/2007
2Vincristine (Oncovin)FDA LinkGeneric
02/2008 - 02/2007
1Messenger RNA (mRNA)IBA
12/2022
1VaccinesIBA
12/2022
1Bortezomib (Velcade)FDA Link
09/2019
1AnthracyclinesIBA
06/2019
1Natriuretic PeptidesIBA
06/2019
1pomalidomideIBA
05/2019
1ParaproteinsIBA
05/2019
1Tyrosine Kinase InhibitorsIBA
01/2019
1T-Cell Antigen Receptors (T-Cell Receptor)IBA
01/2018
1pegaspargase (Oncaspar)FDA Link
01/2018
1Proteins (Proteins, Gene)FDA Link
07/2017
1Complementary DNA (cDNA)IBA
07/2017
1HLA Antigens (Human Leukocyte Antigens)IBA
01/2015
1Imatinib Mesylate (Gleevec)FDA Link
10/2012
1Biomarkers (Surrogate Marker)IBA
06/2011
1liposomal doxorubicin (Doxil)FDA Link
03/2011
1Monoclonal AntibodiesIBA
09/2009
1L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
10/2008
1Mercaptopurine (6 Mercaptopurine)FDA LinkGeneric
02/2007
1Methotrexate (Mexate)FDA LinkGeneric
02/2007

Therapy/Procedure

7Therapeutics
12/2022 - 02/2007
6Drug Therapy (Chemotherapy)
01/2019 - 02/2007
4Highly Active Antiretroviral Therapy (HAART)
04/2015 - 09/2002
1Artificial Respiration (Mechanical Ventilation)
09/2019
1Stem Cell Transplantation
10/2012
1VAP-cyclo protocol
03/2011